These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 202968)

  • 1. Inhibition of angiotensin-converting enzyme by SQ 14,225 in anesthetized dogs: hemodynamic and renal vascular effects.
    Murthy VS; Waldron TL; Goldberg ME
    Proc Soc Exp Biol Med; 1978 Jan; 157(1):121-4. PubMed ID: 202968
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypotension induced by inhibition of angiotensin-converting enzyme in pentobarbital-anesthetized dogs.
    Vollmer RR; Boccagno JA; Harris DN; Murthy VS
    Eur J Pharmacol; 1978 Sep; 51(1):39-45. PubMed ID: 212276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of captopril, a converting enzyme inhibitor on renal vascular resistance in pentobarbital anesthetized dogs.
    Satoh S; Fujisawa S; Tanaka R; Nakai K
    Jpn J Pharmacol; 1980 Aug; 30(4):515-9. PubMed ID: 7009942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism of the hypotensive action of SQ-14225, an angiotensin-converting enzyme inhibitor in anesthetized dogs.
    Jandhyala BS; Nandiwada P; Buckley JP; Lokhandwala MF
    Res Commun Chem Pathol Pharmacol; 1979 Sep; 25(3):429-46. PubMed ID: 228363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of a phosphorus-containing novel angiotensin converting enzyme inhibitor, SQ 29 852 in anesthetized dogs.
    Ohara N; Yokota S; Konishi C; Shukunobe K; Ono H
    J Pharmacobiodyn; 1991 Dec; 14(12):655-62. PubMed ID: 1812274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of captopril on the renal hemodynamics during aprotinin infusion in anesthetized dogs.
    Mizumura Y; Matsumoto M; Nishino A; Takata M; Iida H; Sugimoto T
    Ren Physiol; 1984; 7(5):299-303. PubMed ID: 6207570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of inhibition of angiotensin I converting enzyme with SQ-14225 on the arterial blood pressure of mongrel dogs.
    Jandhyala BS; Washington GF; Lokhandwala MF
    Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):257-65. PubMed ID: 216064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiotensin-converting enzyme inhibition by captopril on cardiac output, coronary blood flow, and systemic arterial blood pressure in the intact and in the bilaterally nephrectomized rabbit.
    Ohmae M; Rabkin SW; Fung HY
    J Cardiovasc Pharmacol; 1981; 3(5):1060-7. PubMed ID: 6168851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic systemic and pulmonary hemodynamic effects of angiotensin converting enzyme inhibition with captopril in hypertensive patients.
    Fagard R; Amery A; Reybrouck T; Lijnen P; Billiet L
    Am J Cardiol; 1980 Aug; 46(2):295-300. PubMed ID: 6250392
    [No Abstract]   [Full Text] [Related]  

  • 10. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
    Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
    Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition.
    Clappison BH; Anderson WP; Johnston CI
    Kidney Int; 1981 Nov; 20(5):615-20. PubMed ID: 6283229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of extrarenal and intrarenal converting enzyme inhibition in renal vasodilator response to intravenous captopril.
    Wong PC; Zimmerman BG
    Life Sci; 1980 Oct; 27(14):1291-7. PubMed ID: 6255273
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of SQ 14,225, an orally active inhibitor of angiotensin-converting enzyme on blood pressure, heart rate and plasma renin activity of conscious normotensive dogs.
    Harris DN; Heran CL; Goldenberg HJ; High JP; Laffan RJ; Rubin B; Antonaccio MJ; Goldberg ME
    Eur J Pharmacol; 1978 Oct; 51(4):345-9. PubMed ID: 213295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional hemodynamic effects of a digitalis glycoside in the conscious dog with and without experimental heart failure.
    Higgins CB; Vatner SF; Braunwald E
    Circ Res; 1972 Apr; 30(4):406-17. PubMed ID: 5013857
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential systemic and regional hemodynamic profiles of four angiotensin-I converting-enzyme inhibitors in the rat.
    Richer C; Doussau MP; Giudicelli JF
    Cardiovasc Drugs Ther; 1989 Dec; 3(6):865-72. PubMed ID: 2562138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central cardiovascular effects of SQ 14,225, an angiotensin-converting enzyme inhibitor in chloralose-anesthetized cats.
    Vollmer RR; Boccagno JA
    Eur J Pharmacol; 1977 Sep; 45(2):117-25. PubMed ID: 198216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypotensive effect of captopril, an angiotensin converting enzyme inhibitor in pentobarbital anesthetized dogs.
    Satoh S; Fujisawa S; Tanaka R; Nakai K
    Jpn J Pharmacol; 1980 Feb; 30(1):112-5. PubMed ID: 6249947
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of acute hemodynamic effects of MC-838, a new angiotensin-converting enzyme inhibitor, with captopril in anesthetized dogs.
    Noguchi K; Kato T; Sunagawa R; Miyamoto Y; Sakanashi M
    Jpn J Pharmacol; 1986 Mar; 40(3):373-80. PubMed ID: 3012164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hemodynamic effects of the active metabolite of imidapril, (4S)-3-((2S)-2-[N-((1S)-1-carboxy-3-phenyl-propyl)amino]propionyl)-1- methyl-2-oxoimidazolidine-4-carboxylic acid, and enalaprilat in anesthetized dogs.
    Ikeo T; Yabana H; Kurosawa H; Kaburaki M; Kikkawa K; Narita H; Murata S; Yamaguchi I
    Arzneimittelforschung; 1992 Sep; 42(9):1109-14. PubMed ID: 1332727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responses of renal, coronary and vertebral vasculatures to MC-838 and captopril in anesthetized dogs.
    Noguchi K; Kato T; Sunagawa R; Sakanashi M
    Pharmacology; 1987; 34(1):48-56. PubMed ID: 3033709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.